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Objective: To analyse the prevalent microorganisms and their antimicrobial resistance
among  intensive care unit patients in a tertiary care centre in New Delhi.
Methods:  A retrospective study of all consecutive blood cultures from various intensive care
unit patients in the hospital during four years (January 2008 to December 2011). Antibiotic
consumption  data in the intensive care units were also analysed during the same period.
Results: Out of the total 22,491 blood cultures processed, 2846 samples were  positive and
3771  microorganisms were isolated. The blood culture positivity was estimated as 12.7%
of  which 67.5% were monomicrobial and 32.5% polymicrobial infections. Gram negative
bacilli,  Gram positive cocci, and fungi were isolated in 49%, 33%, and 18% cases, respectively.
Coagulase  negative staphylococcus was the commonest single isolate followed by Candida
spp.  A drastic shift in the distribution of Candida spp. towards nonalbicans along with high
resistance  to azole group of antifungals suggest echinocandins for the empiric therapy of
candidemia. High penicillin resistance in Gram positive isolates suggest vancomycin, line-
zolid and tigecycline as the options for empiric therapy, whereas tigecycline and colistin
are  the only options remaining for highly resistant Gram negative isolates. Aminoglyco-
sides  were observed to have better sensitivity and reduced usage when compared with
cephalosporins  and -lactam + -lactam inhibitor combinations.Conclusions: High frequencies of multidrug resistant organisms were observed in intensive
care  units which is a warning as to use the only few effective antimicrobials wisely to reduce
selective  pressure on sensitive strains.
tance  pattern may  vary in different intensive care units (ICUs)
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDntroductionnfections caused by multidrug resistant bacteria constitute
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depending  upon the antibiotic pressure in that health care
facility.  This information could be beneﬁcial in choosing the
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appropriate antimicrobials, which in turn can reduce the
length  of stay as well as the morbidity and mortality in ICU
patients.1
The paradox remains where the antibiotics are needed
the  most (ICU), there the highest resistance, is observed
due  to multiple reasons. Random use of high-end antimicro-
bials  has the risk of eventually selecting out mutants that
are  multidrug resistant. Every hospital must recognize the
epidemiology of its microorganisms to recommend initial
appropriate presumptive antimicrobial therapy. The applica-
tion  of hospital-wide antibiograms to guide clinicians in the
initial  choice of antimicrobials is the usual approach adopted.
If  more  resistant organisms are isolated from ICU patients,
this  important information would be masked by the use of
hospital-wide antibiogram.
Here  we  have made an attempt to analyse the prevalent
microorganisms causing blood stream infection (BSI) and their
antimicrobial resistance as seen among the ICU patients in a
tertiary care centre in New Delhi.
Materials  and  methods
Patients
This retrospective study was  conducted for a period of four
years  (January 2008 to December 2011) in a 650-bed tertiary
care  centre in New Delhi. A total of 22,491 blood samples were
analysed  from the patients admitted in various ICUs in the
hospital,  which include general adult ICU, coronary care unit
(CCU),  surgical ICU, and the liver, kidney and bone marrow
transplant ICUs.
Sample  collection  and  processing
Five to 10 mL  of blood sample was  collected and were
inoculated immediately into BacT/ALERT culture bottles
(bioMerieux, Durham, North Carolina, USA) under complete
aseptic  conditions and were  processed as per the manufac-
turer’s  speciﬁcations.
Identiﬁcation  and  susceptibility  testing  of  isolates
Positive blood culture isolates were identiﬁed using VITEK
2  automated system (bioMerieux, Durham, North Carolina).
MIC  was  conﬁrmed using E-test (bioMerieux, France) in case
of  VRE. In case of any discrepancy E-test result was  taken
as  ﬁnal. Susceptibility testing was  performed by Kirby Bauer
method  for tigecycline (15 g, Oxoid Ltd., Basingstoke, Hamp-
shire,  England), and colistin (10 g, HiMedia Laboratories,
Mumbai) and results interpreted as per Clinical Laboratory
Standards Institute (CLSI) guidelines2 and British society for
Antimicrobial Chemotherapy (BSAC) guidelines where ever
CLSI  guidelines were  not available.3 Daptomycin MIC  was
determined for Staphylococcus aureus and Enterococcus spp.
using  E-test during the period of 2010 and 2011. Antibiotic
resistance data were  extracted from the hospital information
system (Intersystems, Cambridge, MA,  USA) using a software
Speedminer (Petaling Jaya, Malaysia) and analysed using a cus-
tomized software, Wattal-Protech, Delhi, India. 1 4;1  8(3):245–251
Screening  for  carbapenem  resistance
Because of the observation of high carbapenem resistance
among Enterobacteriaceae at our facility, we tried to assess
the  magnitude of different mechanisms of carbapenem resis-
tance.  All consecutive isolates of Enterobacteriaceae were
screened  for carbapenem resistance by modiﬁed Hodge test
(MHT)  during the period of December 2010 to April 2011.
All  MHT positive isolates were  further tested for metallo--
lactamase (MBL) by MBL E-test strips (bioMerieux, France).
Further conﬁrmation of all MBL  positive isolates for New Delhi
Metallo-beta-lactamases (NDM-1) was  done using a real time
polymerase  chain reaction (PCR) assay for the detection of the
blaNDM-1 using Taq Man  probes.4
Antifungal  susceptibility  testing
Antifungal susceptibility testing was  performed against
amphotericin B, 5-ﬂucytosine, ﬂuconazole, itraconazole, and
voriconazole  by broth microdilution using API system (ATB
FUNGUS  3, bioMerieux, France), during 2008. For isolates
wherein API system was  not recommended by the manu-
facturer, sensitivity was  done using E-test for amphotericin
B,  ﬂuconazole, and voriconazole. During 2009–2011, antifun-
gal  susceptibility testing was done using VITEK 2 automated
system except for caspofungin, which was done using E-test.
Results  were interpreted as per the CLSI guidelines.5
Antimicrobial  consumption  data
Four years antimicrobial consumption data were  evaluated
from  the antibiotic dispensing data from the hospital infor-
mation  system. Customized software Speedminer was  used
to  extract the data from the hospital information system. The
amount  of antimicrobial drug in grams was  converted into the
number  of deﬁned daily doses (DDDs)/100 bed-days using ABC
calc.6
Ethical  considerations
The study was  approved by the hospital ethics commit-
tee  (reference number EC/09/12/414 and approval letter
dated  31/01/2013). Consent was  waived since this was  an
anonymised study with retrospective evaluation.
Results
A total of 2846 samples were positive from 22,491 blood
cultures received from the study group. The blood culture pos-
itivity  rate in our ICUs was  estimated to be 12.7%. A total of
3771  microorganisms were isolated from 2846 episodes of BSIs.
67.5% (1921/2846) of infections were monomicrobial, while
32.5%  (925/2846) were  polymicrobial (Fig. 1).
Analysis of these isolates showed that the commonest
single isolate among our ICU patients was coagulase nega-
tive  staphylococcus (CoNS) (20.3%) followed by Candida spp.
(17.5%).  Gram negative bacilli (GNB), Gram positive cocci
(GPC),  and fungi were  isolated in 49%, 33%, and 18% cases,
respectively. Among GNB, Klebsiella spp. was  the commonest
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Fig. 1 – Distribution of the various microorganisms from blood culture from ICU patients.
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aollowed by Acinetobacter spp. Candida tropicalis and Candida
aemulonii were  the most frequently isolated Candida spp.
ntimicrobial  susceptibility  testing
atterns of antimicrobial susceptibility for the major
athogens are shown in Tables 1 and 2. The evidence
enerated here indicates that antibiotics like penicillins and
ost  cephalosporins would not be effective against Gram
ositive  and negative bacteria in the ICU. For highly resistant
acteria,  especially Klebsiella spp. and Acinetobacter spp., which
ere  also the commonest gram negative isolates in our ICUs
ven  -lactam + -lactam inhibitor (BL + BLI) combinations
nd carbapenems were  not effective. Amikacin was  slightly
Table 1 – Percentage resistance of antimicrobial agents in the G
E. coli Klebsiella
Ampicillin 96 NT 
Ceftriaxone 91 96 
Ceftazidime NT NT 
Cefepime 90 95 
Gentamicin 64 88 
Amikacin 20 66 
Ciproﬂoxacin 93 91 
Piperacillin + tazobactam 49 85 
Cefoperazone + sulbactum 35 82 
Ertapenem 13 70 
Imipenem/meropenem 12 77 
Tigecycline 0 28 
Colistin 0 0 
ICU, Intensive care unit; NT, not tested.better  and the only remaining effective antibiotics were
tigecycline and colistin.
Carbapenem  resistant  Enterobacteriaceae
A total of 34 Enterobacteriaceae isolates (7 Escherichia coli
and  27 Klebsiella pneumoniae) were  subjected for carbapene-
mase screening. The overall prevalence of carbapenemase
production (MHT positive isolates), MBLs (MBL E-test positive
isolates)  and KPC (MHT positive and MBL  negative) was
52.9%,  41.2% and 11.8%, respectively (Table 5). Interestingly
all  the phenotypically MBL positive isolates, tested for NDM-1
by  PCR were  positive, implying 100% concordance between
the  phenotypic presence of MBLs and presence of blaNDM-1.
ram negative bacilli.
Percentage resistance
 spp. Acinetobacter spp. Pseudomonas aeruginosa
99 NT
99 NT
NT 58
94 60
86 73
78 68
89 71
90 45
79 64
NT NT
83 67
47 NT
0.5 0
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Table 2 – Percentage resistance of Gram positive bacteria to antimicrobial agents.
Antimicrobial agent Percentage resistance
S. aureus CoNS Enterococcus spp. Strep. pneumoniae
Penicillin 100 99.5 NT 16
Ampicillin NT NT 77 NT
Oxacillin 47 94 NT NT
Ceftriaxone NT NT NT 0
Clindamycin 49 80 NT NT
Levoﬂoxacin NT NT NT 0
Gentamicin 56 72 NT NT
Gentamicin120 NT NT 84 NT
Vancomycin 0 0 23 0
Linezolid 0 NT 0 NT
Tigecycline 0 NT 0 NT
Daptomycin 0 NT 0 NT
T, no
positivity  of CoNS isolates can help to differentiate between
potential contaminants and true pathogens.11,12
Table 4 – Percentage resistance of common candida
isolates to antifungals.
Most common
pathogens (n=)
Antifungal (percentage resistance)
C. tropicalis (130) Amphotericin B (0), Caspofungin (0),
Voriconazole (1.2), Fluconazole (3.6),
Flucytosine (6.5)
C. haemulonii (118) Flucytosine (21.3), Caspofungin (4.9),ICU, intensive care unit; CoNS, coagulase negative staphylococcus; N
Fourteen K. pneumoniae (51.9%) and no E. coli isolates were
observed to be NDM-1 producers.
The amount of antimicrobials used during the same time
period  is given in Table 3. The distribution of various candida
species  and their antifungal susceptibility pattern are given in
Table  4.
Discussion
Keeping in view the source of patients to our ICU being from
all  over the city and other parts of the country including
tertiary care centres, this ecology could be representative
of most of the ICUs in the country. In our study, coagu-
lase negative staphylococci were the most common blood
culture  isolate (20.3%) (Fig. 1). Some other studies in our coun-
try  (Mukherjee et al., 61%) as well as from other countries
(Japoni et al., 67.7%, Karlowsky et al., 42%) also observed
CoNS as the commonest blood stream isolate.7–9 In a review
by  Valles et al. who  reviewed more  than ﬁve recent publica-
tions  from different parts of the world also observed CoNS as
the  commonest microorganism (20–30%) causing BSIs among
ICU  patients.1 Appropriate antimicrobial therapy and con-
trol  measures could be adopted to prevent cross infection
Table 3 – Antimicrobial use during 2008–2011.
Antimicrobial class DDD/100 bed days
Penicillins 3.62
Total cephalosporins 25.92
Total BL–BLI combinations 27.62
Quinolones 10.45
Aminoglycosides 8.60
Clindamycin 8.13
Carbapenem 17.38
Glycopeptides 10.11
Linezolid 1.72
Colistin 6.23
Tigecycline 2.74
Total 122.52
DDD, deﬁned daily doses; BL + BLI = -lactam + -lactam inhibit.t tested.
of multidrug-resistant CoNS bacteria from patient-to-patient
and ICU environment. Moreover, CoNS isolates are often skin
colonizers  and appear in blood culture as common contam-
inants  at the time of sample collection.10 Meticulous skin
disinfection at the time of venepuncture can limit this poten-
tial  contaminant species to a large extent. Clinical correlation
of  the blood culture isolate and determination of time toVoriconazole (20.7), Fluconazole (96.7),
Amphotericin B (98.1)
C. parapsilosis (109) Amphotericin B (0), Flucytosine (1.4),
Caspofungin (0), Voriconazole (17),
Fluconazole (37.4)
C. albicans (104) Amphotericin B (0), Caspofungin (0),
Voriconazole (0), Fluconazole (0.8),
Flucytosine (2.5)
C. glabrata (55) Amphotericin B (0), Flucytosine (0),
Caspofungin (0), Voriconazole (13.6),
Fluconazole (25.8)
Table 5 – Mechanism of carbapenem resistance among
Enterobacteriaceae (December 2010 to April 2011).
MHT
positive
MHT positive
and MBL positive
(NDM-1)
MHT  positive
and  MBL
negative (KPC)
E. coli 1 (4.3) 0 (0) 1 (14.3)
K. pneumoniae 17 (63) 14 (51.9) 3 (11.1)
MHT, modiﬁed Hodge test; MBL, metallo--lactamase. Figures in
parenthesis denotes percentage.
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Considering the fact that CoNS isolated from blood cul-
ures  are often contaminants,10 Candida spp. (17.5%) was  the
ommonest  single isolate in the current study (Fig. 1). Studies
ave  proven the various risk factors associated with candida
nfection  in ICU patients which include exposure to multiple
ntibiotics, indwelling catheters, parenteral nutrition, pre-
ious  surgery and presence of a solid organ malignancy.13
andida remains a major cause of BSIs in ICU patients
orldwide.14,15 In fact a major increase in candida BSI started
uring  the 1980s.16 According to the surveillance data from the
S  Centers for Disease Control and Prevention (CDC), candida
ccounts  for 12% of all hospital-acquired BSIs.17 Another inter-
sting  observation is the shift in the distribution of Candida
pp.  responsible for BSI to non-albicans species. In our study
andida  albicans accounted for only 15.3% of candida BSIs. This
pidemiologic  trend has also been observed in many  studies
n  different parts of the world.18,19 This could be attributed
o the increased use of ﬂuconazole as observed in another
tudy  in our hospital.20 Even though C. tropicalis, the com-
onest  candida isolate in our ICUs still remains susceptible
o  most of the antifungals, C. haemulonii, the 2nd commonest
solate, has shown very high resistance to ﬂuconazole and
ven  to amphotericin B. In other studies also, C. haemulonii has
hown increased MICs and frank resistance to both ampho-
ericin  B and ﬂuconazole and has resulted in clinical failure.21
ur susceptibility data suggests that reduced susceptibility to
uconazole is common in Candida glabrata and Candida parap-
ilosis,  and it may  prove simpler in clinical practice to use an
lternative  agent to treat candidaemia due to these species.
educed  susceptibility to ﬂuconazole in C. glabrata was  con-
istent  with previously reported data.22,23 In contrast, C.
arapsilosis has usually been reported to be sensitive to azoles.
Enterococcus  spp. also was  observed as an important
athogen in our study (8.4%). Enterococci form part of the nor-
al  ﬂora of the gastrointestinal tract and female genitourinary
ract.  Over the past decade, vancomycin resistant enterococci
VRE)  have emerged as a leading cause of nosocomial infec-
ions  due to its spread by direct patient-to-patient contact
nd  by indirect transmission via hospital personnel, environ-
ental  surfaces and hospital equipment. In our study, 23% of
nterococci  were VRE, while Japoni et al. reported 10.5% VRE
mong  blood stream isolates in ICU.8 A study by the CDC also
eported  high prevalence of VRE (29%), similar to our study,
mong  the enterococcal infections in ICU settings.24 Still van-
omycin  can serve as an important antibiotic in our ICU to
ontrol  CoNS, S. aureus and streptococcal infections. In the
ase  of S. aureus and CoNS, 47% and 94% of isolates were
esistant to methicillin respectively. Our ﬁndings are simi-
ar  to other studies that report an MRSA rate in ICU varying
etween 47 and 65%.9,25,26 All the MRSA and VRE isolates in
ur  study were  sensitive to vancomycin/teicoplanin, linezolid,
igecycline  as well as daptomycin.
Penicillin  resistance was  observed in 16% (ﬁve isolates) of
.  pneumoniae isolates, all of which were  having an MIC in
he  moderately sensitive range (MIC 0.25–1 g/mL). The rate of
esistance  was  similar to some other studies in India quoting
27–29–18%  penicillin resistance. There was  no frank penicillin
esistance or multidrug resistance, unlike some other studies
rom  India.28,29 All the isolates were sensitive to ceftriaxone
nd quinolones.4;1 8(3):245–251  249
Gram  negative bacteria caused more  than half of the
BSIs  in the current study of ICUs. This observation in our
study  is in agreement with many  other studies from India
as  well as from different parts of the world, even though
the  distribution of various Gram negative pathogens tend to
vary among the different ICUs.30,31 This study documents
the extent of drug resistance among the frequently iso-
lated  Gram negative isolates from intensive care patients.
An  interesting observation of this analysis is the compara-
tively better sensitivity of aminoglycoside against the majority
of  GNB. Similar observations of better aminoglycoside sen-
sitivity  (50–60%) among respiratory isolates was observed by
other  authors as well.32,33 High resistance to cephalosporins
and BL + BLI combinations observed in our study might be
due  to the selective inﬂuence of extensive usage of these
antimicrobials as compared to aminoglycoside (see Table 3).
Our  results show a high prevalence of carbapenem resistance
among  non-fermenters, higher in Acinetobacter spp. (83%)
followed  by Pseudomonas aeruginosa (67%). Carbapenem resis-
tance  observed in Acinetobacter isolates was much  higher
compared to some recent studies in ICUs where the resis-
tance  is reported to be 16–17%.8,30,34 The trend of carbapenem
resistance in the past decade indicates signiﬁcant increase in
resistance in Acinetobacter spp. with no signiﬁcant change in
P. aeruginosa.35,36 Our study shows that, among Enterobacte-
riaceae, K. pneumoniae has emerged as a problematic species
in  our health care settings as compared to E. coli due to
high  prevalence of carbapenemases, which are predominantly
NDM-1. Though KPC was previously thought to be the main
mechanism of resistance among Enterobacteriaceae, the data
in  our study shows that MBL has replaced other mecha-
nism of carbapenem resistance. In-fact all isolates positive
for  MBL phenotypically were  also positive for NDM-1 by PCR.
The  rapidly emerging NDM-1 is of concern from the per-
spective of infection control not only because of their broad
-lactam  resistance coverage but also due to their transmissi-
bility. Additionally we tested few strains of non-fermenters (20
P.  aeruginosa and seven Acinetobacter spp.) for the presence of
blaNDM-1. Surprisingly we detected the presence of blaNDM-1 in
one  isolate of Acinetobacter baumannii. Sporadic cases of NDM-
1  producing acinetobacter strains have also been reported
around the world37 highlighting its spread to non-fermenters
also. Tigecycline, introduced in 2006 in our hospital for MDR
bacteria,  has lost its effectiveness in 47% of Acinetobacter spp.
and  28% of Klebsiella spp. among our blood stream isolates in
ICU.  Currently, colistin remains the only therapeutic option
for  the majority of ICU patients, although high-quality phar-
macokinetic data and clinical outcome studies are lacking
for  polymyxin therapy. Among Enterobacteriaceae, Klebsiella
spp.  with 77% carbapenem resistance appears to be at par
with  the Acinetobacter spp. (83%). The rapidly increasing preva-
lence  of Enterobacteriaceae harbouring carbapenemases is
alarming. Some other recent studies have also reported high
carbapenem  resistance (77.8%) in K. pneumonia from ICU.38
On studying the pattern of consumption of various antibi-
otics  in the ICUs, an increase in the usage of second-line
antibiotics with broad spectrum of activity and reserved for
multidrug  resistant organisms was  observed in our ICUs. The
selection  pressure associated with the use of high-end antimi-
crobials  might have led to the predominance of multidrug
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resistant isolates in our ICUs. Even though a direct relation-
ship  between the quantity of antimicrobials used and the
development of resistance is not easy to establish, studies
have  documented that the indiscriminate use of antimicro-
bials  has led to the selection of drug-resistant organisms.35,39
An increase in the prevalence of non-fermenters might have
led  to an increase in the usage of second-line antibiotics such
as  -lactam/inhibitor combinations and carbapenems.
In conclusion, BSI caused by multidrug resistant pathogens
including, MRSA, VRE, carbapenem resistant Enterobac-
teriaceae, non-fermenters and non-albicans Candida spp.
comprise  the current infection proﬁle of the ICUs. Linezolid,
tigecycline and vancomycin are the most reliable treatment
options  for GPC and colistin alone or in combination with
carbapenems or aminoglycosides appear to be the remaining
treatment options for such Gram negative infections. De-
escalation  of the high-end antimicrobials once the sensitivity
pattern  of the isolate is known is suggested to reduce the
antimicrobial pressure. More  aggressive measures such as rou-
tine screening cultures to identify and isolate carriers and
the  various environmental sources are also recommended,
as  well as periodical antibacterial sensitivity assessment in
ICUs  because of the continuous changes in the antibacterial
susceptibility patterns.
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